NCT07189260Recruiting
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia in Patients Undergoing Hip Fracture Surgery
Source: ClinicalTrials.gov · Last updated 23 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients. * Does pre- and postoperative treatment with systematic PEP therapy prevent hospital-acquired pneumonia in patients with hip fracture? * Which barriers do participants have regarding PEP therapy in this group of patients? Researchers will compare systematic PEP therapy to no intervention besides standard treat-ment to see if systematic therapy with PEP can prevent hospital-acquired pneumonia. Participants will: * Receive systematic PEP therapy during hospitalization or no intervention besides standard treatment * Register the PEP therapy four times daily on a paper checklist. Failure to perform the treatment and the reason must also be documented on the checklist.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 566 (estimated)
- First submitted
- 11 Jun 2025
- Start date
- 19 Feb 2024
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- University Hospital Bispebjerg and Frederiksberg
- Diseases
- Osteoporosis
- NCT number
- NCT07189260
What you commit to
- Study type: Interventional
- Planned participants: 566
- From 19 Feb 2024 to the primary completion date, 31 Dec 2029
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pneumothorax
- For patients with e.g. dementia or brain injury, the ability to give informed consent will be assessed individually.
Other
- Cognitively impaired
- Unable to understand the study and give informed consent
- Pneumonia upon admission
- Delirium upon admission
Who the study is looking for
- Hip fracture regardless of age
- Cognitively well-functioning
- Able to understand the study and give informed consent
- Able to speak and understand Danish
- Resident of Region Hovedstaden or Region Sjælland
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bispebjerg-Frederiksberg Hospital Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
| Herlev & Gentofte Hospital Coordinator of this site? Confirm its status | Herlev | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.